NDC 60505-7078
Buprenorphene
Buprenorphene
Buprenorphene is a Transdermal Patch, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Apotex Corp.. The primary component is Buprenorphine.
| Product ID | 60505-7078_47eb2ff6-1cee-2ea0-558c-99d51c900b13 |
| NDC | 60505-7078 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Buprenorphene |
| Generic Name | Buprenorphene |
| Dosage Form | Patch, Extended Release |
| Route of Administration | TRANSDERMAL |
| Marketing Start Date | 2021-09-29 |
| Marketing Category | ANDA / |
| Application Number | ANDA210272 |
| Labeler Name | Apotex Corp. |
| Substance Name | BUPRENORPHINE |
| Active Ingredient Strength | 15 mg/h |
| Pharm Classes | Partial Opioid Agonists [MoA],Partial Opioid Agonist [EPC] |
| DEA Schedule | CIII |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |